TG Therapeutics Inc (TGTX)

Exchange
NASDAQ
Symbol
TGTX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York.
Country
USA

Stock price

At close: November 21, 2025

  • Open
    30.40
  • High
    32.11
  • Low
    30.32
  • Close
    31.95
  • Volume
    2,686,010

Financial ratios

Dec 31, 2024